close

LATEST POSTS from Anne-Lise Berthier

Vivet Therapeutics receives €4.9 million to advance development of a gene therapy for the treatment of cerebrotendinous xanthomatosis

Vivet Therapeutics receives €4.9 million to advance development of a gene therapy for the treatment of cerebrotendinous xanthomatosis  Funding from French Government as part of the France Health Innovation Plan 2030 Vivet Therapeutics, a French clinical stage biotech company developing novel and long-lasting gene therapies for rare inherited metabolic disorders,…..

New approach to single-cell RNA structure sequencing unveils biomarkers for human development and disease

New approach to single-cell RNA structure sequencing unveils biomarkers for human development and disease Different cells have different RNA structures and studying those structures offers insights into cell functions. © A*STAR’s GIS Researchers from A*STAR’s Genome Institute of Singapore (GIS) have found an innovative approach to sequencing single-cell RNA to…..

NIH study shows how genes in retina get regulated during development

NIH study shows how genes in retina get regulated during development Genome topology map of human retina development lays foundation for understanding diverse clinical phenotypes in simple and complex eye diseases [caption id="" align="aligncenter" width="555"] This image metaphorically captures the cell differentiation process during retinal organoid development. Loose yarn representing…..

Clean Cells opens new production suites close to Nantes

Clean Cells opens new production suites close to Nantes Clean Cells, part of the Clean Biologics group, a French provider of biopharmaceutical product quality control services and manufacturer of starting materials, has launched operations in its new production suites, located in the new facility opened in January 2023, in Montaigu-Vendée,…..

DREAMS: a new Horizon Europe project combining AI and stem cells for the treatment of neuromuscular diseases

DREAMS: a new Horizon Europe project combining AI and stem cells for the treatment of neuromuscular diseases [caption id="attachment_11533" align="aligncenter" width="270"] ©ISTEM[/caption] In a groundbreaking endeavour set to span five years, the DREAMS consortium is paving the way for a novel approach to treating neuromuscular diseases. This transformative project merges…..